Key result
Pediatric DCM reactivates ~8% of the fetal gene program in cardiomyocytes and fibroblasts.
Why the study?
To what extent is the human fetal gene program recapitulated across cardiomyocytes and non-myocyte cardiac cell types in pediatric dilated cardiomyopathy?
To what extent is the human fetal gene program recapitulated across cardiomyocytes and non-myocyte cardiac cell types in pediatric dilated cardiomyopathy?
Answers are grounded in this paper and cite their sources.
Demonstrates at single-cell resolution that fetal gene reactivation in pediatric dilated cardiomyopathy is not restricted to cardiomyocytes, occurring at a similar proportion (~8%) across all subclusters of both cardiomyocytes and cardiac fibroblasts.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Mehdiabadi et al. (2022) studied Pediatric dilated cardiomyopathy (DCM). Early-onset pediatric dilated cardiomyopathy (single-nucleus RNA sequencing transcriptional profiling) vs. Fetal (19-20 weeks) and pediatric nondiseased (4-14 years) left ventricular tissue was evaluated on Proportion of developmentally regulated fetal genes reactivated in DCM versus nondiseased hearts (FDR <0.05, |log2 fold change| >1.5) (p=FDR <0.05). Single-nucleus RNA sequencing in pediatric dilated cardiomyopathy revealed that ~8% of the fetal gene program is reactivated in both cardiomyocytes (163/2079 genes) and fibroblasts (139/1658 genes).
Synapse has enriched 10 related papers. Consider them for comparative context: